Description
+ Include: 15 videos + 1 pdf, size: 4.02 GB
+ Target Audience: oncologists
+ Sample video: contact me for sample video
+ Information:
This virtual symposium will have expert review of the latest procedures, technology and medical treatments for GI cancer patients. National guidelines will be reviewed. Emphasis will be on multi-disciplinary care, novel new drugs that have been recently FDA-approved, and upcoming clinical trials. This symposium is for physicians, nurse practitioners, physician assistants, pharmacists, and oncology nurses who care for cancer patients.
This activity is intended for physicians, nurse practitioners, physician assistants, pharmacists and oncology nurses. Trainees, at all levels, are highly encouraged to attend.
EDUCATIONAL OBJECTIVES
Upon completion of this education activity, learners should be able to:
- Recognize the multi-disciplinary approach (interventional radiology, surgery, radiation oncology, and medical oncology) to treating GI cancers
- Identify and use the new oncologic drugs for GI cancers and know the ongoing clinical trials
- Incorporate multi-disciplinary approach towards their patient care and offer an increased number of treatment options for the patients.
+ Topics:
Agenda.pdf
SESSION 1 COLORECTAL CANCER CASE PRESENTATION Q&A.mp4
SESSION 1 COLORECTAL CANCER DEBATE- TNT FOLLOWED BY SURGERY VS. CHEMORADIOTHERAPY ONLY FOLLOWED BY SURGERY.mp4
SESSION 1 COLORECTAL CANCER ROLE OF ctDNA IN EARLY AND ADVANCED CRC.mp4
SESSION 1 COLORECTAL CANCER UPDATES IN MANAGEMENT OF METASTATIC CRC IN ERA OF COMPREHENSIVE GENOMIC ANALYSIS.mp4
SESSION 2 HEPATO-PANCREATO-BILIARY MALIGNANCIES CASE PRESENTATION Q&A.mp4
SESSION 2 HEPATO-PANCREATO-BILIARY MALIGNANCIES CURRENT TREATMENT LANDSCAPE IN PANCREATIC CANCER 1.mp4
SESSION 2 HEPATO-PANCREATO-BILIARY MALIGNANCIES CURRENT TREATMENT LANDSCAPE IN PANCREATIC CANCER 2.mp4
SESSION 2 HEPATO-PANCREATO-BILIARY MALIGNANCIES HIGH-RISK BILIARY CANCER – IS THERE A ROLE FOR NEOADJUVANT THERAPY.mp4
SESSION 2 HEPATO-PANCREATO-BILIARY MALIGNANCIES ROLE OF NGS IN BILIARY CANCER MANAGEMENT.mp4
SESSION 2 HEPATO-PANCREATO-BILIARY MALIGNANCIES SEQUENCING THERAPY IN HCC- A GOOD PROBLEM TO HAVE.mp4
SESSION 3 OTHER GI MALIGNANCIES CASE PRESENTATION Q&A.mp4
SESSION 3 OTHER GI MALIGNANCIES DEBATE- 2ND LINE TREATMENT FOR PNET- PRRT VS TKI 2.mp4
SESSION 3 OTHER GI MALIGNANCIES DEBATE- 2ND LINE TREATMENT FOR PNET- PRRT VS TKI.mp4
SESSION 3 OTHER GI MALIGNANCIES IMMUNOTHERAPY IN GEJ GASTRIC CANCERS- ARE WE THERE YET.mp4
SESSION 3 OTHER GI MALIGNANCIES WHAT’S NEW IN ANAL CANCER MANAGEMENT.mp4
Reviews
There are no reviews yet.